Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 53 min ago
Peer-reviewedCC BY-NC-NDClinical and translational science

Healthy Participant Versus Patient Selection for Clinical Pharmacology Studies in Small-Molecule Oncology Drug Development.

  1. 1Clinical Pharmacology, Bristol Myers Squibb, Princeton, New Jersey, USA.

Related

  1. Bayesian Optimization for Dose Finding with Two Agents: Participant Allocation and Final Selection
    Xinzhu Wang, Tanzy Love
    arXivPreprintarXiv licenceFull textStatisticsarXiv
  2. Valid Data‐Driven Subgroup Selection With Uniform Guarantees in Clinical Trials
    Manuel M. Müller, Björn Bornkamp, Frank Bretz +7
    Statistics in medicinePeer-reviewedCC BYFull textStatisticsEurope PMC
  3. HALO: Hierarchical Evidence Selection and Reinforcement Learning for Allocating Budgeted Label Optimization from Longitudinal Clinical Records
    Huaiyuan Ying, Feiqing Huang, Ryumei Nakada +2
    arXivPreprintCC BY-NC-SA 4.0Full textStatisticsarXiv
  4. Methods for Assessing Distributional Assumptions in Individual Participant Data Meta-Analysis of Diagnostic Tests
    Diribsa T. Bedada, Zelalem F. Negeri
    arXivPreprintarXiv licenceFull textStatisticsarXiv
  5. Influence of continuous predictor modelling methods on prediction stability in clinical prediction model development: an empirical comparison using real clinical data
    Phichayut Phinyo, Pakpoom Wongyikul, Noraworn Jirattikanwong +5
    arXivPreprintCC BY-NC-ND 4.0Full textStatisticsarXiv
BibTeX
@article{gupta2026healthy,
  title = {{Healthy Participant Versus Patient Selection for Clinical Pharmacology Studies in Small-Molecule Oncology Drug Development.}},
  author = {Paridhi Gupta and Zheyi Hu and Li Zhu and Lora Hamuro},
  journal = {Clinical and translational science},
  year = {2026},
  month = nov,
  doi = {10.1111/cts.70769},
  url = {https://europepmc.org/article/MED/42967603},
  note = {CC BY-NC-ND},
}
RIS
TY  - JOUR
TI  - Healthy Participant Versus Patient Selection for Clinical Pharmacology Studies in Small-Molecule Oncology Drug Development.
AU  - Paridhi Gupta
AU  - Zheyi Hu
AU  - Li Zhu
AU  - Lora Hamuro
PY  - 2026
DA  - 2026/11/01
JO  - Clinical and translational science
DO  - 10.1111/cts.70769
UR  - https://europepmc.org/article/MED/42967603
SN  - 1752-8054
SN  - 1752-8062
ER  -